[Advantages of different dosages of active metabolites in the follow-up of azathioprine treatment for Crohn disease].
Cagnard
B
B
Département de médecine de l'enfant et de l'adolescent, CHU-Hôpital-Sud, 16, boulevard de Bulgarie, 35056 Rennes 02, France.
Tosoni-Verlingue
D
D
Tribut
O
O
Moizard
C
C
Bridoux-Henno
L
L
Delaperriere
N
N
Bentue-Ferrer
D
D
Dabadie
A
A
D000293:Adolescent; D001379:Azathioprine / Q000008:administration & dosage* / Q000378:metabolism*; D002648:Child; D002675:Child, Preschool; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006150:Guanine Nucleotides / Q000378:metabolism*; D006801:Humans; D008297:Male; D013873:Thionucleotides / Q000378:metabolism*
D006150:Guanine Nucleotides; D013873:Thionucleotides; C003964:6-thioguanylic acid; D001379:Azathioprine